Posted: June 20, 2014 - 7:45 pm ET
Federal regulators have approved a new antibiotic drug intended for use against antimicrobial-resistant skin infections.The Food and Drug Administration late Friday announced it has approved for sale the drug Sivextro, produced by Massachusetts-based drugmaker Cubist Pharmaceuticals, for the...